Comera Life Sciences Holdings Inc

Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Athersys

Chimerix

InflaRx

Revelation Biosciences

Biotech penny stocks to watch this week. The post Best Penny Stocks To Buy As Recession Begins?

Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch

Dave

Helix Energy Solutions Group

Imperial Petroleum

Penny stocks are some of the most volatile investments in the stock

Best Penny Stocks To Buy? 4 To Watch After PGY Stock Explodes 790%

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, expanded its patent portfolio with the issuance of U.S. Patent No. 11,357,857 (the ‘857 patent), which provides Comera exclusive rights pertaining to certain excipients in its SQore™ platform as viscosity-lowering agents to significantly optimize filtration efficiency of pr

Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform

Hims & Hers Health

Nerdy

Penny stocks to watch right now. The post 3 Top Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Top Stocks To Watch Before Next Week

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of Michael Campbell as Executive Vice President and Chief Financial Officer. He had served as interim Chief Financial Officer since April 13, 2022 and will continue to oversee Comera's finance operations, including accounting and reporting, c

Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer

News for Comera Life Sciences Holdings Inc Stock (CMRA)